AJ Vaccines A/S: Financial statements 2020
CVR: 37911143
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 351,618,000 and a net result of DKK -450,212,000 compared with DKK -288,603,000 the year before. That is an increase of 8.7% compared with the year before. The profit margin was -128%. Equity in the 2020 report amounted to DKK 1,052,358,000. The solvency ratio was 60.9%. The company had 702 employees in the financial year.
- Revenue
- DKK 351,618,000
- Gross Profit
- DKK -313,896,000
- Profit/Loss
- DKK -450,212,000
- Equity
- DKK 1,052,358,000
- Total Assets
- DKK 1,727,645,000
- Employees
- 702
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 351.6M | -313.9M | -450.2M | 1.1B | 702 |
| 2019 | 323.5M | -224.5M | -288.6M | 1.2B | 719 |
| 2018 | 362.2M | -150.7M | -244.5M | 903.2M | 0 |
Official annual report
How creditworthy is AJ Vaccines A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
AJ Vaccines A/S has published its annual report for 2019. Revenue came to DKK 323,471,000, and the net result was DKK -288,603,000.
As of May 28, 2020, Shan-E-Abbas Ashary has joined the board of directors of AJ Vaccines A/S.
As of May 28, 2020, Abdul Wahab Mohammed A Alesayi has joined the board of directors of AJ Vaccines A/S.
As of May 28, 2020, Saddam Abdulqawi Hussein Alhumaikani has joined the board of directors of AJ Vaccines A/S.
As of May 28, 2020, Jesper Helmuth Larsen has left the board of directors of AJ Vaccines A/S.
As of March 23, 2020, Saddam Abdulqawi Hussein Alhumaikani has left the board of directors of AJ Vaccines A/S.
About AJ Vaccines A/S
AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.
